This Health Industry Insights Perspective provides insights on the robust translational research system being implemented at the Dana-Farber Cancer Institute. This solution aspires to fully institutionalize access to patient and clinical data, fully protect patient rights and privacy, and enable real-time query capabilities to allow Dana-Farber researchers to both perform cutting-edge translational research and effectively leverage patient sample resources in pursuit of new grant proposals. To achieve these goals, Dana-Farber has architected a robust IT infrastructure built on InforSense and Oracle product solutions, creating a solution that is only limited by the queries for which researchers have Institutional Review Board (IRB) approval to ask.

This Perspective provides insights developed from direct discussions with Dr. John Quackenbush at Dana-Farber and Joseph Donahue from InforSense.

Related Reports:
Collaboration Cubed: Industry, Government, and Academia Working Together to Improve Health
Laboratory Information Management Systems
China Healthcare Vertical Industry IT Solution Market Competition Landscape
Healthcare Computer System Markets and Trends In HIT Buying (Forecasts for System, Service and Support Revenues, Areas of Interest, Major Competitor Profiles)
Healthcare Information Technology
High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer)
Hospital Information Systems Market in Europe
Hospital Information Systems
The 2009-2014 Outlook for Unitary Air Conditioners Excluding Air Source Heat Pumps in Greater China
Canadian Acute Care: IT Investment and Deployment Strategies